Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)

SHA:688161 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,393	1,451	1,282	2,057	2,152	1,822
Other Revenue	2.21	2.21	1.33	0.93	1.58	1.47
Revenue	1,395	1,453	1,284	2,058	2,154	1,824
Revenue Growth (YoY)	12.35%	13.18%	-37.63%	-4.44%	18.08%	15.87%
Cost of Revenue	501.95	537.6	460.3	489.5	409.09	338.96
Gross Profit	893.04	915.12	823.24	1,568	1,744	1,485
Selling, General & Admin	526.93	573.21	621.81	786.46	827.36	710.75
Research & Development	119.02	119.9	130.2	117.66	121.23	82.46
Other Operating Expenses	12.84	13.73	14.21	28.89	31.26	40.25
Operating Expenses	649.89	698.56	760.93	948.03	983.99	837.56
Operating Income	243.15	216.56	62.31	620.45	760.46	647.25
Interest Expense	-0.92	-1.04	-0.95	-0.61	-0.61	-
Interest & Investment Income	46.02	44.8	56.11	64.57	42.93	15.41
Currency Exchange Gain (Loss)	-1	-1	-1.24	2.18	-0.51	-2.44
Other Non Operating Income (Expenses)	-2.2	-1.18	10.58	6.02	-6.28	-0.35
EBT Excluding Unusual Items	285.06	258.14	126.82	692.6	795.99	659.88
Impairment of Goodwill	-0.24	-0.24	-0.17	-	-	-
Gain (Loss) on Sale of Investments	0.54	0.32	0.13	-	-	-
Gain (Loss) on Sale of Assets	6.37	6.35	-0.02	0.23	-0.11	-0.45
Asset Writedown	0.13	-	-	-	-	-1.6
Other Unusual Items	6.36	6.36	4.86	13.38	14.05	8.2
Pretax Income	298.22	270.94	131.62	706.21	809.93	666.03
Income Tax Expense	53.24	42.66	18.53	105.85	118.59	104.31
Earnings From Continuing Operations	244.98	228.29	113.09	600.36	691.33	561.72
Minority Interest in Earnings	-4.35	-4.53	-0.78	0.35	-1.01	-3.32
Net Income	240.64	223.75	112.32	600.7	690.32	558.4
Net Income to Common	240.64	223.75	112.32	600.7	690.32	558.4
Net Income Growth	353.32%	99.22%	-81.30%	-12.98%	23.62%	26.43%
Shares Outstanding (Basic)	402	400	401	400	379	358
Shares Outstanding (Diluted)	402	400	401	400	379	358
Shares Change (YoY)	0.54%	-0.39%	0.16%	5.58%	5.96%	7.79%
EPS (Basic)	0.60	0.56	0.28	1.50	1.82	1.56
EPS (Diluted)	0.60	0.56	0.28	1.50	1.82	1.56
EPS Growth	350.88%	100.00%	-81.33%	-17.58%	16.67%	17.29%
Free Cash Flow	293.57	249.85	76.46	392.8	675.84	594.54
Free Cash Flow Per Share	0.73	0.63	0.19	0.98	1.78	1.66
Dividend Per Share	0.290	0.290	0.120	0.410	0.520	-
Dividend Growth	140.70%	140.70%	-70.62%	-21.15%	-	-
Gross Margin	64.02%	62.99%	64.14%	76.22%	81.00%	81.41%
Operating Margin	17.43%	14.91%	4.86%	30.15%	35.31%	35.49%
Profit Margin	17.25%	15.40%	8.75%	29.19%	32.05%	30.62%
Free Cash Flow Margin	21.04%	17.20%	5.96%	19.09%	31.38%	32.60%
EBITDA	295.35	269.9	120.22	677.35	811.94	688.9
EBITDA Margin	21.17%	18.58%	9.37%	32.91%	37.70%	37.77%
D&A For EBITDA	52.2	53.34	57.91	56.91	51.48	41.65
EBIT	243.15	216.56	62.31	620.45	760.46	647.25
EBIT Margin	17.43%	14.91%	4.86%	30.15%	35.31%	35.49%
Effective Tax Rate	17.85%	15.74%	14.08%	14.99%	14.64%	15.66%
Revenue as Reported	-	-	-	2,058	2,154	1,824

Source: S&P Global Market Intelligence. Standard template. Financial Sources.